Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1974 4
1975 2
1976 1
1977 2
1978 4
1980 3
1981 4
1982 7
1983 9
1984 5
1985 3
1986 7
1987 2
1988 2
1989 5
1990 8
1991 7
1992 7
1993 6
1994 1
1995 10
1996 10
1997 4
1998 5
1999 1
2000 5
2001 3
2002 5
2003 7
2004 3
2005 4
2006 5
2007 4
2008 9
2009 6
2010 6
2011 11
2012 8
2013 8
2014 6
2015 9
2016 12
2017 10
2018 13
2019 3
2020 13
2021 15
2022 13
2023 13
2024 22
2025 29
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

345 results

Results by year

Filters applied: . Clear all
Page 1
Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial.
Colombo N, Biagioli E, Harano K, Galli F, Hudson E, Antill Y, Choi CH, Rabaglio M, Marmé F, Marth C, Parma G, Fariñas-Madrid L, Nishio S, Allan K, Lee YC, Piovano E, Pardo B, Nakagawa S, McQueen J, Zamagni C, Manso L, Takehara K, Tasca G, Ferrero A, Tognon G, Lissoni AA, Petrella M, Laudani ME, Rulli E, Uggeri S, Barretina Ginesta MP; AtTEnd study group. Colombo N, et al. Among authors: harano k. Lancet Oncol. 2024 Sep;25(9):1135-1146. doi: 10.1016/S1470-2045(24)00334-6. Epub 2024 Aug 2. Lancet Oncol. 2024. PMID: 39102832 Clinical Trial.
Laterally π-Extended Polyhelicenes.
Wu H, Qiu Z, Wen G, Hinaut A, Harano K, Graf R, Prezzi D, Estaque L, Tsai YL, Schollmeyer D, Pieters G, Molinari E, Pawlak R, Meyer E, Kimoto K, Wang HI, Bonn M, Müllen K, Narita A. Wu H, et al. Among authors: harano k. J Am Chem Soc. 2025 Nov 26;147(47):43842-43849. doi: 10.1021/jacs.5c15494. Epub 2025 Nov 14. J Am Chem Soc. 2025. PMID: 41237299 Free PMC article.
Impact of germline variants on breast and ovarian cancer risk in Japanese women: an original cohort study and meta-analysis.
Yazaki S, Hori M, Aiba H, Momozawa Y, Yoshida M, Shiino S, Harano K, Yamauchi C, Yamanaka T, Miwa M, Matsuda K, Kawai Y, Kobayashi-Kato M, Kitagawa M, Saito M, Nakagomi H, Tachibana K, Sakamoto I, Takahashi K, Asami Y, Katanoda K, Kuchiba A, Yoshida H, Ishikawa M, Shimoi T, Sudo K, Shimizu C, Shimomura A, Murata T, Yamashita Y, Kogawa T, Fujiwara S, Saji H, Kato H, Miyagi E, Iwasaki Y, Aoi T, Takata S, Ogasawara A, Ohtake T, Fujimori K, Hirotsu Y, Nagashima M, Komatsu M, Hamamoto R, Hirata M, Yoshida T, Honda T, Hiranuma K, Matsuda M, Shimada Y, Sunami K, Noiri E, Omae Y, Matsumoto K, Okamoto A, Omata M, Watanabe T, Miyagi Y, Murakami Y, Tokunaga K, Hasegawa K, Kato T, Onishi T, Yamashita T, Naito Y, Suto A, Yonemori K, Kohno T, Shiraisihi K; BioBank Japan Project; NCBN Controls WGS Consortium. Yazaki S, et al. Among authors: harano k. EBioMedicine. 2025 Jun;116:105758. doi: 10.1016/j.ebiom.2025.105758. Epub 2025 May 21. EBioMedicine. 2025. PMID: 40403695 Free PMC article.
Forward-genetics analysis of sleep in randomly mutagenized mice.
Funato H, Miyoshi C, Fujiyama T, Kanda T, Sato M, Wang Z, Ma J, Nakane S, Tomita J, Ikkyu A, Kakizaki M, Hotta-Hirashima N, Kanno S, Komiya H, Asano F, Honda T, Kim SJ, Harano K, Muramoto H, Yonezawa T, Mizuno S, Miyazaki S, Connor L, Kumar V, Miura I, Suzuki T, Watanabe A, Abe M, Sugiyama F, Takahashi S, Sakimura K, Hayashi Y, Liu Q, Kume K, Wakana S, Takahashi JS, Yanagisawa M. Funato H, et al. Among authors: harano k. Nature. 2016 Nov 17;539(7629):378-383. doi: 10.1038/nature20142. Epub 2016 Nov 2. Nature. 2016. PMID: 27806374 Free PMC article.
Germline Pathogenic Variants and Clinical Outcomes in Asian Patients With Breast Cancer.
Kitadai R, Yazaki S, Kuchiba A, Yamanaka T, Shiino S, Yamauchi C, Harano K, Saito M, Hirotsu Y, Aiba H, Yoshida T, Hamamoto R, Shimizu C, Shimomura A, Kojima Y, Shimoi T, Momozawa Y, Sudo K, Yoshida M, Sunami K, Hori M, Katanoda K, Shimada Y, Yamashita Y, Kogawa T, Murata T, Fujiwara S, Miyagi Y, Nakagomi H, Tachibana K, Omata M, Ohtake T, Suto A, Onishi T, Naito Y, Yamashita T, Yonemori K, Kohno T, Shiraishi K. Kitadai R, et al. Among authors: harano k. Cancer Sci. 2025 Apr;116(4):1048-1058. doi: 10.1111/cas.70002. Epub 2025 Feb 10. Cancer Sci. 2025. PMID: 39930910 Free PMC article.
Japan Society of Gynecologic Oncology 2023 guidelines for treatment of uterine body neoplasm.
Morisada T, Kobayashi Y, Nagase S, Baba T, Tokunaga H, Watari H, Takekuma M, Terao Y, Terai Y, Kajiyama H, Asai-Sato M, Takehara K, Tabata T, Harano K, Hirashima Y, Yunokawa M, Okamoto A, Mikami M. Morisada T, et al. Among authors: harano k. J Gynecol Oncol. 2025 May;36(3):e119. doi: 10.3802/jgo.2025.36.e119. J Gynecol Oncol. 2025. PMID: 40395085 Free PMC article.
Phase III double-blind randomized placebo controlled trial of atezolizumab in combination with carboplatin and paclitaxel in women with advanced/recurrent endometrial carcinoma: the Asian cohort of the AtTEnd/ENGOT-EN7 trial.
Harano K, Fossati R, Pardo B, Galli F, Hudson E, Antill Y, Lee C, Rabaglio M, Heitz F, Kolovetsiou-Kreiner V, Lai CH, Biagioli E, Manso L, Nishio S, Allan K, Lee YC, Uggeri S, Redondo A, Nakagawa S, Au E, Lombard J, Gadducci A, Takehara K, Baldini EE, Palaia I, Casanova C, Ardizzoia A, Bologna A, Barretina-Ginesta MP, Colombo N. Harano K, et al. J Gynecol Oncol. 2025 Jul;36(4):e117. doi: 10.3802/jgo.2025.36.e117. J Gynecol Oncol. 2025. PMID: 40590326 Free PMC article. Clinical Trial.
Niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer: final results of a multicenter phase 2 study.
Aoki D, Tabata T, Yanagida S, Nakamura T, Kondo E, Hamanishi J, Harano K, Hasegawa K, Hirasawa T, Hori K, Komiyama S, Matsuura M, Nakai H, Nakamura H, Sakata J, Takehara K, Takekuma M, Yokoyama Y, Kase Y, Sumino S, Soeda J, Kato A, Suri A, Okamoto A, Sugiyama T. Aoki D, et al. Among authors: harano k. J Gynecol Oncol. 2024 Sep;35(5):e114. doi: 10.3802/jgo.2024.35.e114. J Gynecol Oncol. 2024. PMID: 39251349 Free PMC article. Clinical Trial.
Benefits of Combining Circulating Tumor DNA With Tissue and Longitudinal Circulating Tumor DNA Genotyping in Advanced Solid Tumors: SCRUM-Japan MONSTAR-SCREEN-1 Study.
Fujisawa T, Nakamura Y, Bando H, Morizane C, Ikeda M, Nonomura N, Matsubara N, Iwata H, Naito Y, Okano S, Aoki D, Harano K, Yamazaki N, Namikawa K, Ueno M, Kadowaki S, Oki E, Kato K, Komatsu Y, Satoh T, Esaki T, Denda T, Hamaguchi T, Yamazaki K, Matsuhashi N, Yasui H, Satake H, Nishina T, Takahashi N, Goto M, Sunakawa Y, Kato T, Otsuka T, Abutani H, Tukachinsky H, Lee JK, Oxnard GR, Kuramoto N, Horasawa S, Sakamoto Y, Taniguchi H, Yoshino T. Fujisawa T, et al. Among authors: harano k. JCO Precis Oncol. 2025 Apr;9:e2400283. doi: 10.1200/PO.24.00283. Epub 2025 Apr 10. JCO Precis Oncol. 2025. PMID: 40209142 Free PMC article.
Pan-Asia adapted ESMO Clinical Practice Guideline for the management of patients with newly diagnosed and relapsed epithelial ovarian cancer.
Nag S, Ray Coquard I, Gupta S, Pathak A, Li N, Mulya Sari R, Harano K, Kim GM, Ang SF, Que FV, Chay WY, Lai HC, Ativitavas T, Tangjitgamol S, Lai CH, Heong VYM, Contreras Tolentino J, Ngu MR, Yun J, Yunokawa M, Hanafi WLH, Li J, Smyth E, Yoshino T, Mehta J, Pentheroudakis G, Maheshwari A, Cervantes A, Basade M, Oaknin A. Nag S, et al. Among authors: harano k. ESMO Open. 2025 Jun;10(6):105125. doi: 10.1016/j.esmoop.2025.105125. Epub 2025 Jun 9. ESMO Open. 2025. PMID: 40494042 Free PMC article.
345 results